76 related articles for article (PubMed ID: 20938960)
1. Increased amphiregulin expression as a biomarker of cholesteatoma activity.
Macias MP; Gerkin RD; Macias JD
Laryngoscope; 2010 Nov; 120(11):2258-63. PubMed ID: 20938960
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression in cholesteatoma by DNA chip analysis.
Macias JD; Gerkin RD; Locke D; Macias MP
Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
[TBL] [Abstract][Full Text] [Related]
3. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
[TBL] [Abstract][Full Text] [Related]
4. Cholesteatoma growth and proliferation: relevance with serpin B3.
Ho KY; Huang HH; Hung KF; Chen JC; Chai CY; Chen WT; Tsai SM; Chien CY; Wang HM; Wu YJ
Laryngoscope; 2012 Dec; 122(12):2818-23. PubMed ID: 23239141
[TBL] [Abstract][Full Text] [Related]
5. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack.
Enomoto Y; Orihara K; Takamasu T; Matsuda A; Gon Y; Saito H; Ra C; Okayama Y
J Allergy Clin Immunol; 2009 Nov; 124(5):913-20.e1-7. PubMed ID: 19895983
[TBL] [Abstract][Full Text] [Related]
6. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
8. Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts.
Wang SW; Oh CK; Cho SH; Hu G; Martin R; Demissie-Sanders S; Li K; Moyle M; Yao Z
J Allergy Clin Immunol; 2005 Feb; 115(2):287-94. PubMed ID: 15696083
[TBL] [Abstract][Full Text] [Related]
9. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
10. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract][Full Text] [Related]
11. Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts.
Inatomi O; Andoh A; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
Int J Mol Med; 2006 Sep; 18(3):497-503. PubMed ID: 16865236
[TBL] [Abstract][Full Text] [Related]
12. The imbalance of enzymatic antioxidants in cholesteatoma.
Eskiizmir G; Yuceturk AV; Onur E; Var A; Temiz P
Acta Otolaryngol; 2009 Nov; 129(11):1187-91. PubMed ID: 19863309
[TBL] [Abstract][Full Text] [Related]
13. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma.
Cinamon U; Kronenberg J; Benayahu D
Laryngoscope; 2000 Jul; 110(7):1198-203. PubMed ID: 10892696
[TBL] [Abstract][Full Text] [Related]
14. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast stimulating and differentiating factors in human cholesteatoma.
Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
Sikka K; Sharma SC; Thakar A; Dattagupta S
J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
[TBL] [Abstract][Full Text] [Related]
17. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
18. The value of scutum erosion in the diagnosis of temporal bone cholesteatoma.
Yu Z; Han D; Gong S; Wang Z; Zhang L
Acta Otolaryngol; 2010; 130(1):47-51. PubMed ID: 19579143
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
20. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M
Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
